Cheyne Capital Management (UK) LLP - Q1 2023 holdings

$31.5 Million is the total value of Cheyne Capital Management (UK) LLP's 22 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 100.0% .

 Value Shares↓ Weighting
GBIO ExitGENERATION BIO CO$0-51,126
-100.0%
-0.35%
SWN ExitSOUTHWESTERN ENERGY CO$0-37,000
-100.0%
-0.38%
RRC ExitRANGE RES CORP$0-9,000
-100.0%
-0.39%
GRCL ExitGRACELL BIOTECHNOLOGIES INCsponsored ads$0-98,120
-100.0%
-0.39%
DTIL ExitPRECISION BIOSCIENCES INC$0-190,065
-100.0%
-0.40%
LRMR ExitLARIMAR THERAPEUTICS INC$0-63,680
-100.0%
-0.46%
ALBO ExitALBIREO PHARMA INC$0-13,364
-100.0%
-0.50%
VERV ExitVERVE THERAPEUTICS INC$0-15,000
-100.0%
-0.51%
MRTX ExitMIRATI THERAPEUTICS INC$0-6,650
-100.0%
-0.53%
ABOS ExitACUMEN PHARMACEUTICALS INC$0-55,829
-100.0%
-0.53%
ICPT ExitINTERCEPT PHARMACEUTICALS IN$0-26,443
-100.0%
-0.57%
ExitMOONLAKE IMMUNOTHERAPEUTICSclass a ord$0-32,129
-100.0%
-0.59%
ExitAMYLYX PHARMACEUTICALS INC$0-9,499
-100.0%
-0.61%
KALV ExitKALVISTA PHARMACEUTICALS INC$0-52,790
-100.0%
-0.62%
EQT ExitEQT CORP$0-12,200
-100.0%
-0.72%
SRPT ExitSAREPTA THERAPEUTICS INC$0-3,650
-100.0%
-0.83%
CBAY ExitCYMABAY THERAPEUTICS INC$0-77,499
-100.0%
-0.85%
TVTX ExitTRAVERE THERAPEUTICS INC$0-23,750
-100.0%
-0.87%
OXY ExitOCCIDENTAL PETE CORPcall$0-302
-100.0%
-0.94%
AVTE ExitAEROVATE THERAPEUTICS INC$0-18,927
-100.0%
-0.97%
PTCT ExitPTC THERAPEUTICS INC$0-15,106
-100.0%
-1.01%
CCJ ExitCAMECO CORP$0-25,700
-100.0%
-1.02%
DAWN ExitDAY ONE BIOPHARMACEUTICALS I$0-27,223
-100.0%
-1.02%
VKTX ExitVIKING THERAPEUTICS INC$0-64,753
-100.0%
-1.06%
ExitVENTYX BIOSCIENCES INC$0-20,035
-100.0%
-1.15%
OPTN ExitOPTINOSE INC$0-394,737
-100.0%
-1.28%
RARE ExitULTRAGENYX PHARMACEUTICAL IN$0-17,115
-100.0%
-1.39%
HRTX ExitHERON THERAPEUTICS INC$0-318,008
-100.0%
-1.39%
ACRS ExitACLARIS THERAPEUTICS INC$0-50,964
-100.0%
-1.40%
ExitCINCOR PHARMA INC$0-67,557
-100.0%
-1.45%
BABA ExitALIBABA GROUP HLDG LTDsponsored ads$0-9,800
-100.0%
-1.51%
ISEE ExitIVERIC BIO INC$0-41,250
-100.0%
-1.54%
PNT ExitPOINT BIOPHARMA GLOBAL INC$0-127,090
-100.0%
-1.62%
SGEN ExitSEAGEN INC$0-8,025
-100.0%
-1.80%
BILL ExitBILL COM HLDGS INC$0-10,940
-100.0%
-2.08%
PLRX ExitPLIANT THERAPEUTICS INC$0-66,144
-100.0%
-2.23%
PCVX ExitVAXCYTE INC$0-26,849
-100.0%
-2.25%
HTHT ExitH WORLD GROUP LTDsponsored ads$0-31,000
-100.0%
-2.30%
ALPN ExitALPINE IMMUNE SCIENCES INC$0-181,886
-100.0%
-2.34%
MSOS ExitADVISORSHARES TRpure us cannabis$0-202,000
-100.0%
-2.47%
RAPT ExitRAPT THERAPEUTICS INC$0-71,828
-100.0%
-2.48%
XENE ExitXENON PHARMACEUTICALS INC$0-42,500
-100.0%
-2.93%
FTCH ExitFARFETCH LTDord sh cl a$0-416,500
-100.0%
-3.44%
RDNT ExitRADNET INC$0-111,427
-100.0%
-3.67%
CHK ExitCHESAPEAKE ENERGY CORP.$0-39,506
-100.0%
-6.51%
ATVI ExitACTIVISION BLIZZARD INC$0-103,136
-100.0%
-13.80%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-03
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BARRICK GOLD CORPORATION37Q3 202311.8%
RADNET INC28Q4 20226.2%
PRICELINE GRP INC17Q2 20216.7%
BIOMARIN PHARMACEUTICAL INC17Q2 20222.8%
INSMED INC17Q2 20221.5%
SPIRIT RLTY CAP INC NEW16Q1 20214.7%
ARES CAPITAL CORP15Q4 20213.8%
NRG ENERGY INC14Q1 20233.9%
APOLLO GLOBAL MGMT LLC14Q2 20192.5%
TWITTER INC13Q2 20226.7%

View Cheyne Capital Management (UK) LLP's complete holdings history.

Latest significant ownerships (13-D/G)
Cheyne Capital Management (UK) LLP Q1 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
TELULAR CORPMay 31, 2013903,3155.2%
TITAN INTERNATIONAL INCSold outFebruary 04, 200900.0%
PORTA SYSTEMS CORPAugust 13, 20087,038,23670.7%
TERRA NOSTRA RESOURCES CORP.February 14, 20085,975,91410.1%
GREAT ATLANTIC & PACIFIC TEA CO INCOctober 29, 20072,034,6334.8%
Horsehead Holding CorpOctober 18, 20071,461,5384.2%
UNITED RENTALS INC /DEOctober 16, 20074,260,8705.0%
Huntsman CORPOctober 02, 200710,999,9705.0%
TANOX INCSold outAugust 09, 200700.0%

View Cheyne Capital Management (UK) LLP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-12
13F-HR2023-10-27
13F-HR2023-07-14
13F-HR2023-05-03
13F-HR2023-02-10
13F-HR/A2022-11-10
13F-HR2022-11-09
13F-HR2022-08-05
13F-HR2022-05-10
13F-HR2022-01-26

View Cheyne Capital Management (UK) LLP's complete filings history.

Compare quarters

Export Cheyne Capital Management (UK) LLP's holdings